Literature DB >> 3048802

Amniotic fluid folate, vitamin B12 and transcobalamins in neural tube defects.

P Gardiki-Kouidou1, M J Seller.   

Abstract

Levels of folate, vitamin B12, the vitamin B12 binding proteins, apotranscobalamin I, II and III (TC I, II and III) and the unsaturated vitamin B12 binding capacity (UBBC) were measured in mid-trimester amniotic fluids from normal pregnancies, and from those where the fetus had open spina bifida, anencephaly or omphalocoele, and where the fetus was normal but the mother had had a previous neural tube defect pregnancy. At 15-19 weeks' gestation, vitamin B12 levels were low in the fluids of all the types of abnormal fetuses, and also of normal fetuses where there had been a previous NTD sib. In contradistinction, TC I, II and III and UBBC levels were generally abnormally high in all these groups. Low vitamin B12 levels in the face of high carrier protein levels suggest deranged vitamin B12 production or transport. Since these abnormalities are present in fluids from normal sibs of NTD individuals as well as from those with midline lesions, an inherited defect is implied. We propose that at least part of the genetic predisposition to NTD, and possibly other midline defects, could reside in an abnormality connected with vitamin B12 production, transport or metabolism, and a mechanism is suggested.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3048802     DOI: 10.1111/j.1399-0004.1988.tb03478.x

Source DB:  PubMed          Journal:  Clin Genet        ISSN: 0009-9163            Impact factor:   4.438


  9 in total

Review 1.  Clinical risk factors for gastroschisis and omphalocele in humans: a review of the literature.

Authors:  Polina Frolov; Jasem Alali; Michael D Klein
Journal:  Pediatr Surg Int       Date:  2010-08-31       Impact factor: 1.827

2.  Transcobalamin II receptor polymorphisms are associated with increased risk for neural tube defects.

Authors:  F Pangilinan; A Mitchell; J VanderMeer; A M Molloy; J Troendle; M Conley; P N Kirke; M Sutton; J M Sequeira; E V Quadros; J M Scott; J L Mills; L C Brody
Journal:  J Med Genet       Date:  2010-06-24       Impact factor: 6.318

Review 3.  Neural tube defects and folate: case far from closed.

Authors:  Henk J Blom; Gary M Shaw; Martin den Heijer; Richard H Finnell
Journal:  Nat Rev Neurosci       Date:  2006-09       Impact factor: 34.870

4.  Folic acid in early pregnancy: a public health success story.

Authors:  Sarah G Obican; Richard H Finnell; James L Mills; Gary M Shaw; Anthony R Scialli
Journal:  FASEB J       Date:  2010-07-14       Impact factor: 5.191

5.  Maternal vitamin B12 status and risk of neural tube defects in a population with high neural tube defect prevalence and no folic Acid fortification.

Authors:  Anne M Molloy; Peadar N Kirke; James F Troendle; Helen Burke; Marie Sutton; Lawrence C Brody; John M Scott; James L Mills
Journal:  Pediatrics       Date:  2009-03       Impact factor: 7.124

6.  Joint effects of prenatal air pollutant exposure and maternal folic acid supplementation on risk of autism spectrum disorder.

Authors:  Amanda J Goodrich; Heather E Volk; Daniel J Tancredi; Rob McConnell; Fred W Lurmann; Robin L Hansen; Rebecca J Schmidt
Journal:  Autism Res       Date:  2017-11-09       Impact factor: 4.633

Review 7.  Vitamin B(12) metabolism during pregnancy and in embryonic mouse models.

Authors:  Maira A Moreno-Garcia; David S Rosenblatt; Loydie A Jerome-Majewska
Journal:  Nutrients       Date:  2013-09-10       Impact factor: 5.717

Review 8.  Should vitamin B12 status be considered in assessing risk of neural tube defects?

Authors:  Anne M Molloy
Journal:  Ann N Y Acad Sci       Date:  2018-01-29       Impact factor: 5.691

Review 9.  Neural tube defects, folic acid and methylation.

Authors:  Apolline Imbard; Jean-François Benoist; Henk J Blom
Journal:  Int J Environ Res Public Health       Date:  2013-09-17       Impact factor: 3.390

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.